Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

BUY
$22.67 - $35.0 $937,019 - $1.45 Million
41,333 Added 10.21%
446,061 $12.4 Million
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $9.72 Million - $14.7 Million
404,728
404,728 $14.6 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.13B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track State Farm Mutual Automobile Insurance CO Portfolio

Follow State Farm Mutual Automobile Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Farm Mutual Automobile Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on State Farm Mutual Automobile Insurance CO with notifications on news.